Stock Events

Stock Events

Australis Capital 

$0
22
+$0+0% Tuesday 20:00

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
90,656
Avg. Volume
4,392
Mkt Cap
5,218.24
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

1MarExpected
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-0.09
-0.05
-0.02
0.01
Expected EPS
N/A
Actual EPS
-0.0151

Financials

-3,492.02%Profit Margin
Unprofitable
2018
2019
2020
1.13MRevenue
-39.53MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AUSAF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Green Thumb Industries
GTII.CN
Mkt Cap2.65B
Green Thumb Industries Inc. is a competitor due to its involvement in the cultivation, dispensing, and sale of cannabis in the United States, similar to Australis Capital's market.
Trulieve Cannabis
TRUL.CN
Mkt Cap1.8B
Trulieve Cannabis Corp. competes with Australis Capital by operating as a medical and recreational marijuana company in the U.S., focusing on similar product lines and markets.
Cresco Labs
CRLBF
Mkt Cap432.32M
Cresco Labs Inc. is a competitor because it operates as a cannabis company in the U.S., engaging in the cultivation, manufacturing, and retailing of cannabis and cannabis products.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis Inc. competes in the global cannabis market, focusing on both medical and consumer cannabis products, similar to Australis Capital's offerings.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray, Inc. competes with Australis Capital in the cannabis sector, offering a wide range of cannabis products and operating on an international scale.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation is a competitor due to its extensive involvement in the cannabis and hemp business, including cultivation, manufacturing, and retail.
Cronos Group
CRON
Mkt Cap962.94M
Cronos Group Inc. is a competitor in the cannabis industry, focusing on the production and sale of cannabis in an international market, similar to Australis Capital's strategy.

About

Australis Capital Inc. operates as a cannabis company. It undertakes cannabis, as well as horticulture projects in the United States, Canada, Denmark Finland, Iceland, Germany, the Netherlands, Bahrein, the United Arab Emirates, Southeast Asia, and Australia, as well as other jurisdictions. The company is based in Las Vegas, Nevada.
Show more...
CEO
Mr. Terrance R. Booth
Country
CA
ISIN
CA05259R1073

Listings

OTC Link
US
AUSAF

0 Comments

Share your thoughts

FAQ

What is Australis Capital stock price today?▼
The current price of AUSAF is $0 USD — it has increased by +0% in the past 24 hours. Watch Australis Capital stock price performance more closely on the chart.
What is Australis Capital stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Australis Capital stocks are traded under the ticker AUSAF.
What is Australis Capital market cap?▼
Today Australis Capital has the market capitalization of 5,218.24
What were Australis Capital earnings last quarter?▼
AUSAF earnings for the last quarter are -0.02 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Australis Capital revenue for the last year?▼
Australis Capital revenue for the last year amounts to 1.13M USD.
What is Australis Capital net income for the last year?▼
AUSAF net income for the last year is -39.53M USD.
In which sector is Australis Capital located?▼
Australis Capital operates in the Health Care sector.
When did Australis Capital complete a stock split?▼
Australis Capital has not had any recent stock splits.
Where is Australis Capital headquartered?▼
Australis Capital is headquartered in Las Vegas, CA.